Oxysure Systems (OXYS) 0.7775 $OXYS
OxySure(R) Systems, Inc. To Present At Taglich Brothers 11th Annual Small Cap Equity Conference
PRWeb - Wed Apr 23, 3:49AM CDT
OxySure Systems, Inc. is pleased to announce that Julian Ross, CEO of OxySure(R) Systems, Inc. (OTCQB: OXYS) will be presenting at Taglich Brothers 11th Annual Small Cap Equity Conference May 6, 2014. The Conference will take place at the New York Athletic Club, New York City. To request additional information or to register, contact Taglich Brothers at 212-779-2971 or visit http://www.TaglichBrothers.com.
OxySure Systems Picks Up Momentum Going Into 2014
ACCESSWIRE - Tue Apr 22, 8:43AM CDT
WHITEFISH,MT / April 22nd, 2014 / OxySure Systems, Inc. (OTC: OXYS), developer of innovative oxygen-from-powder devices used to dispense emergency medical oxygen, recently reported robust fiscal year 2013 financial results. Revenue surged 566% to over $1.8 million, gross margins jumped from 46.8% to 72.8%, SG&A expenses were down 3%, and the balance sheet sported a healthy 1.88x current ratio.
OxySure Systems (OXYS) Reports Fourth Quarter and Full-Year 2013 Results
Marketwire - Wed Apr 16, 8:04AM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, today announced financial and operating results for the fourth quarter and year ended December 31, 2013.
OxySure Systems (OXYS) to Host Fourth Quarter and Full Year 2013 Financial Results Conference Call at 9:00 am ET on April 16, 2014
Marketwire - Mon Apr 14, 12:23PM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company" , the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced that it will hold a conference call at 9:00 am ET on Wednesday, April 16, 2014 to discuss its financial results for the three and twelve months ended December 31, 2013.
OxySure Moves Higher after Obtaining CE Mark
ACCESSWIRE - Mon Apr 07, 8:16AM CDT
Whitefish, MT / ACCESSWIRE / April 7, 2014 / OxySure Systems Inc. (OTCBB: OXYS), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, jumped more than 5% on higher than average volume following its CE Mark announcement and coverage on InvestmentPitch.com on April 2, 2014.
90 Million Patients With Life Threatening Respiratory Disease Need Medical Oxygen Right Now
GlobeNewswire - Wed Apr 02, 9:03AM CDT
According to the World Health Organisation (WHO), 28% of European adults smoke - compared with 18% in the U.S. Tobacco-related illnesses cause 16% of deaths in Europe, compared with 12% globally. Approximately 250,000 people die each year in Europe because of asthma and other respiratory diseases.
OxySure (OXYS) Announces CE Mark Approval for OxySure Model 615 Portable Emergency Oxygen Device
Marketwire - Wed Apr 02, 8:04AM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company" , a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology is pleased to announce its OxySure Model 615 portable emergency oxygen device has received CE Mark approval, a critical step toward launching this unique product into the thirty countries belonging to the European Economic Area (EEA).
OxySure Systems (OXYS) Announces Investor Update on Annual Report
Marketwire - Mon Mar 31, 3:11PM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company" , the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today provided an investor update regarding the Company's expected reporting timeline for its annual report for the year ending December 31, 2013.
OxySure Systems (OXYS) to Present at Taglich Brothers 11th Annual Small Cap Equity Conference
Marketwire - Thu Mar 27, 8:15AM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company" , the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced that CEO Julian T. Ross will present at the Taglich Brothers 11th Annual Small Cap Equity Conference to be held on Tuesday, May 6, 2014 at the New York Athletic Club, 180 Central Park South in New York City. To register for the conference please click here: https://www.meetmax.com/sched/event_24749/inv...g_new.html ?cmd=register&event_id=24749
OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture
ACCESSWIRE - Mon Mar 10, 8:01AM CDT
Whitefish, MT / March 10, 2014 / The healthcare industry has been attracting record amounts of capital in 2014, driven by biotechnology and pharmaceutical companies bringing new products to market. In fact, more than half of all money flowing into U.S. sector-focused ETFs, or $4.06 billion through February 28th, was placed in healthcare ETFs, according to data compiled by Bloomberg.
OxySure CEO Provides Shareholders With a "State of the Union" Communication
Marketwire Canada - Mon Mar 03, 8:20AM CST
OxySure Systems, Inc. (OTCQB: OXYS), ("OxySure," or the "Company" , the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, announced today the release of a company overview as presented by OxySure's CEO Julian Ross.
Medical Device Innovator OxySure Systems Summarizes Recent Corporate Activities - Video News Alert Summary Hosted on InvestmentPitch.com
Newsfile Corp - Wed Feb 19, 10:18AM CST
full story)
Medical Device Innovator OxySure Systems (OTCQB:OXYS) Summarizes Recent Corporate Activities - Video News Alert Summary Hosted on InvestmentPitch.com
Thomson Reuters ONE - Wed Feb 19, 9:32AM CST
Vancouver, BC, February19, 2014 - OxySure Systems (OTCQB:OXYS) a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, has recent corporate activities summarized in a video by InvestmentPitch. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems.
Bringing Oxygen from First Response to Public Places
ACCESSWIRE - Tue Feb 18, 8:56AM CST
Emergency oxygen can help improve hypoxia - or insufficient oxygen reaching the cells - and reduce pain and breathing discomfort during breathing and cardiac emergencies. In a 2008 audit of oxygen use in ambulances and emergency departments in the U.K., researchers found that oxygen use in ambulances is very common at 2.2 million episodes each year.
OxySure De-Leverages to Improve Shareholder Value and Prepares for an Uplisting
ACCESSWIRE - Mon Feb 03, 9:38AM CST
OxySure Systems Inc. (OTCBB: OXYS), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, recently announced that it removed approximately $967,609 of claimed indebtedness from its balance sheet by converting notes and other indebtedness to restricted common stock at above-market conversion prices of between $0.76 and $1.50 per share.
OxySure Systems (OXYS) to Present at SeeThruEquity Microcap Investor Conference
Marketwire - Mon Feb 03, 8:25AM CST
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company" , the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced that CEO Julian T. Ross will present at the SeeThruEquity Microcap Investor Conference on Thursday, February 6, 2014 at 2:30 pm EST. The Conference will be held at Convene Midtown East (730 Third Avenue) in midtown Manhattan, New York.
OxySure Systems (OXYS) Announces Investor Update Conference Call
Marketwire - Fri Jan 31, 8:25AM CST
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company" , the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced that the Company will host a conference call to update shareholders and other interested parties on Tuesday, February 4, 2014 at 10:30 a.m. Central Time - 11:30 a.m. Eastern Time. Julian T. Ross, Chief Executive Officer and President, will provide a brief update and overview.
S&P Capital IQ Initiates Coverage on OxySure Systems, Inc. in S&P Capital IQ Factual Stock Reports
PR Newswire - Tue Jan 28, 8:36AM CST
S&P Capital IQ announced today that it has commenced Standard & Poor's Factual Stock Report coverage on OxySure Systems, Inc.
OxySure Systems (OXYS) Improves Balance Sheet by Reducing Debt by Nearly $1 Million
Marketwire - Mon Jan 27, 8:25AM CST
OxySure® Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company" , a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, today announced that the Company has removed approximately $967,609 of claimed indebtedness from its balance sheet by converting notes and other indebtedness to restricted common stock at conversion prices ranging from $1.50 per share to $.76 per share.
OxySure(R) Systems, Inc. To Present At Taglich Brothers 11th Annual Small Cap Equity Conference
PRWeb - Wed Apr 23, 3:49AM CDT
OxySure Systems, Inc. is pleased to announce that Julian Ross, CEO of OxySure(R) Systems, Inc. (OTCQB: OXYS) will be presenting at Taglich Brothers 11th Annual Small Cap Equity Conference May 6, 2014. The Conference will take place at the New York Athletic Club, New York City. To request additional information or to register, contact Taglich Brothers at 212-779-2971 or visit http://www.TaglichBrothers.com.
OxySure Systems Picks Up Momentum Going Into 2014
ACCESSWIRE - Tue Apr 22, 8:43AM CDT
WHITEFISH,MT / April 22nd, 2014 / OxySure Systems, Inc. (OTC: OXYS), developer of innovative oxygen-from-powder devices used to dispense emergency medical oxygen, recently reported robust fiscal year 2013 financial results. Revenue surged 566% to over $1.8 million, gross margins jumped from 46.8% to 72.8%, SG&A expenses were down 3%, and the balance sheet sported a healthy 1.88x current ratio.
OxySure Systems (OXYS) Reports Fourth Quarter and Full-Year 2013 Results
Marketwire - Wed Apr 16, 8:04AM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, today announced financial and operating results for the fourth quarter and year ended December 31, 2013. OxySure Systems (OXYS) to Host Fourth Quarter and Full Year 2013 Financial Results Conference Call at 9:00 am ET on April 16, 2014
Marketwire - Mon Apr 14, 12:23PM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced that it will hold a conference call at 9:00 am ET on Wednesday, April 16, 2014 to discuss its financial results for the three and twelve months ended December 31, 2013. OxySure Moves Higher after Obtaining CE Mark
ACCESSWIRE - Mon Apr 07, 8:16AM CDT
Whitefish, MT / ACCESSWIRE / April 7, 2014 / OxySure Systems Inc. (OTCBB: OXYS), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, jumped more than 5% on higher than average volume following its CE Mark announcement and coverage on InvestmentPitch.com on April 2, 2014.
90 Million Patients With Life Threatening Respiratory Disease Need Medical Oxygen Right Now
GlobeNewswire - Wed Apr 02, 9:03AM CDT
According to the World Health Organisation (WHO), 28% of European adults smoke - compared with 18% in the U.S. Tobacco-related illnesses cause 16% of deaths in Europe, compared with 12% globally. Approximately 250,000 people die each year in Europe because of asthma and other respiratory diseases.
OxySure (OXYS) Announces CE Mark Approval for OxySure Model 615 Portable Emergency Oxygen Device
Marketwire - Wed Apr 02, 8:04AM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology is pleased to announce its OxySure Model 615 portable emergency oxygen device has received CE Mark approval, a critical step toward launching this unique product into the thirty countries belonging to the European Economic Area (EEA). OxySure Systems (OXYS) Announces Investor Update on Annual Report
Marketwire - Mon Mar 31, 3:11PM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today provided an investor update regarding the Company's expected reporting timeline for its annual report for the year ending December 31, 2013. OxySure Systems (OXYS) to Present at Taglich Brothers 11th Annual Small Cap Equity Conference
Marketwire - Thu Mar 27, 8:15AM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced that CEO Julian T. Ross will present at the Taglich Brothers 11th Annual Small Cap Equity Conference to be held on Tuesday, May 6, 2014 at the New York Athletic Club, 180 Central Park South in New York City. To register for the conference please click here: https://www.meetmax.com/sched/event_24749/inv...g_new.html ?cmd=register&event_id=24749 OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture
ACCESSWIRE - Mon Mar 10, 8:01AM CDT
Whitefish, MT / March 10, 2014 / The healthcare industry has been attracting record amounts of capital in 2014, driven by biotechnology and pharmaceutical companies bringing new products to market. In fact, more than half of all money flowing into U.S. sector-focused ETFs, or $4.06 billion through February 28th, was placed in healthcare ETFs, according to data compiled by Bloomberg.
OxySure CEO Provides Shareholders With a "State of the Union" Communication
Marketwire Canada - Mon Mar 03, 8:20AM CST
OxySure Systems, Inc. (OTCQB: OXYS), ("OxySure," or the "Company"
, the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, announced today the release of a company overview as presented by OxySure's CEO Julian Ross. Medical Device Innovator OxySure Systems Summarizes Recent Corporate Activities - Video News Alert Summary Hosted on InvestmentPitch.com
Newsfile Corp - Wed Feb 19, 10:18AM CST
full story)
Medical Device Innovator OxySure Systems (OTCQB:OXYS) Summarizes Recent Corporate Activities - Video News Alert Summary Hosted on InvestmentPitch.com
Thomson Reuters ONE - Wed Feb 19, 9:32AM CST
Vancouver, BC, February19, 2014 - OxySure Systems (OTCQB:OXYS) a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, has recent corporate activities summarized in a video by InvestmentPitch. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems.
Bringing Oxygen from First Response to Public Places
ACCESSWIRE - Tue Feb 18, 8:56AM CST
Emergency oxygen can help improve hypoxia - or insufficient oxygen reaching the cells - and reduce pain and breathing discomfort during breathing and cardiac emergencies. In a 2008 audit of oxygen use in ambulances and emergency departments in the U.K., researchers found that oxygen use in ambulances is very common at 2.2 million episodes each year.
OxySure De-Leverages to Improve Shareholder Value and Prepares for an Uplisting
ACCESSWIRE - Mon Feb 03, 9:38AM CST
OxySure Systems Inc. (OTCBB: OXYS), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, recently announced that it removed approximately $967,609 of claimed indebtedness from its balance sheet by converting notes and other indebtedness to restricted common stock at above-market conversion prices of between $0.76 and $1.50 per share.
OxySure Systems (OXYS) to Present at SeeThruEquity Microcap Investor Conference
Marketwire - Mon Feb 03, 8:25AM CST
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced that CEO Julian T. Ross will present at the SeeThruEquity Microcap Investor Conference on Thursday, February 6, 2014 at 2:30 pm EST. The Conference will be held at Convene Midtown East (730 Third Avenue) in midtown Manhattan, New York. OxySure Systems (OXYS) Announces Investor Update Conference Call
Marketwire - Fri Jan 31, 8:25AM CST
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced that the Company will host a conference call to update shareholders and other interested parties on Tuesday, February 4, 2014 at 10:30 a.m. Central Time - 11:30 a.m. Eastern Time. Julian T. Ross, Chief Executive Officer and President, will provide a brief update and overview. S&P Capital IQ Initiates Coverage on OxySure Systems, Inc. in S&P Capital IQ Factual Stock Reports
PR Newswire - Tue Jan 28, 8:36AM CST
S&P Capital IQ announced today that it has commenced Standard & Poor's Factual Stock Report coverage on OxySure Systems, Inc.
OxySure Systems (OXYS) Improves Balance Sheet by Reducing Debt by Nearly $1 Million
Marketwire - Mon Jan 27, 8:25AM CST
OxySure® Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, today announced that the Company has removed approximately $967,609 of claimed indebtedness from its balance sheet by converting notes and other indebtedness to restricted common stock at conversion prices ranging from $1.50 per share to $.76 per share. 
